Peregrine Asset Advisers’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-8,000
Closed -$221K 114
2015
Q4
$221K Hold
8,000
0.19% 80
2015
Q3
$206K Sell
8,000
-1,000
-11% -$25.8K 0.21% 80
2015
Q2
$223K Hold
9,000
0.17% 95
2015
Q1
$227K Hold
9,000
0.15% 107
2014
Q4
$211K Hold
9,000
0.15% 111
2014
Q3
$205K Hold
9,000
0.17% 105
2014
Q2
$220K Buy
+9,000
New +$220K 0.2% 104
2014
Q1
Sell
-9,000
Closed -$214K 145
2013
Q4
$214K Buy
+9,000
New +$214K 0.19% 100

Other funds holding QGENF

Peregrine Asset Advisers's QGENF Position: Q1 2016 in Review

Peregrine Asset Advisers sold out of QIAGEN NV (QGENF) in Q1 2016, closing a stake of 8,000 shares — an estimated $221K sold.

Peregrine Asset Advisers first reported a position in QGENF in Q4 2013 and held it in 8 quarters. The position peaked at $227K in Q1 2015. 201 funds tracked by Wall St. Rank hold QGENF as of Q1 2016.

  • Peregrine Asset Advisers reported no remaining QIAGEN NV position as of Q1 2016 after selling out during the quarter.
  • Peregrine Asset Advisers sold 8,000 QIAGEN NV shares in Q1 2016, an estimated $221K.
  • Peregrine Asset Advisers first reported a position in QIAGEN NV in Q4 2013 and held it in 8 quarters.
  • Peregrine Asset Advisers's QIAGEN NV position peaked at $227K in Q1 2015.
  • 201 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2016.

Based on Peregrine Asset Advisers's 13F filing for Q1 2016, filed 13 May 2016.